Summary
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
According to APO Research, The global Plasma Protein Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Plasma Protein Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Plasma Protein Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Plasma Protein Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Plasma Protein Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Plasma Protein Therapeutics include Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Plasma Protein Therapeutics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Plasma Protein Therapeutics, also provides the sales of main regions and countries. Of the upcoming market potential for Plasma Protein Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plasma Protein Therapeutics sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Plasma Protein Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Plasma Protein Therapeutics sales, projected growth trends, production technology, application and end-user industry.
Plasma Protein Therapeutics segment by Company
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
Plasma Protein Therapeutics segment by Type
Coagulation Factor
Immune Globulin
Albumin
Others
Plasma Protein Therapeutics segment by Application
Hemophilia
PID
Others
Plasma Protein Therapeutics segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Protein Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Protein Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Protein Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Plasma Protein Therapeutics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Plasma Protein Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Protein Therapeutics sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Plasma Protein Therapeutics Market by Type
1.2.1 Global Plasma Protein Therapeutics Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Others
1.3 Plasma Protein Therapeutics Market by Application
1.3.1 Global Plasma Protein Therapeutics Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hemophilia
1.3.3 PID
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Plasma Protein Therapeutics Market Dynamics
2.1 Plasma Protein Therapeutics Industry Trends
2.2 Plasma Protein Therapeutics Industry Drivers
2.3 Plasma Protein Therapeutics Industry Opportunities and Challenges
2.4 Plasma Protein Therapeutics Industry Restraints
3 Global Market Growth Prospects
3.1 Global Plasma Protein Therapeutics Revenue Estimates and Forecasts (2019-2030)
3.2 Global Plasma Protein Therapeutics Revenue by Region
3.2.1 Global Plasma Protein Therapeutics Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Plasma Protein Therapeutics Revenue by Region (2019-2024)
3.2.3 Global Plasma Protein Therapeutics Revenue by Region (2025-2030)
3.2.4 Global Plasma Protein Therapeutics Revenue Market Share by Region (2019-2030)
3.3 Global Plasma Protein Therapeutics Sales Estimates and Forecasts 2019-2030
3.4 Global Plasma Protein Therapeutics Sales by Region
3.4.1 Global Plasma Protein Therapeutics Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Plasma Protein Therapeutics Sales by Region (2019-2024)
3.4.3 Global Plasma Protein Therapeutics Sales by Region (2025-2030)
3.4.4 Global Plasma Protein Therapeutics Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Plasma Protein Therapeutics Revenue by Manufacturers
4.1.1 Global Plasma Protein Therapeutics Revenue by Manufacturers (2019-2024)
4.1.2 Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Plasma Protein Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Plasma Protein Therapeutics Sales by Manufacturers
4.2.1 Global Plasma Protein Therapeutics Sales by Manufacturers (2019-2024)
4.2.2 Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Plasma Protein Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Plasma Protein Therapeutics Sales Price by Manufacturers (2019-2024)
4.4 Global Plasma Protein Therapeutics Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Plasma Protein Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Plasma Protein Therapeutics Manufacturers, Product Type & Application
4.7 Global Plasma Protein Therapeutics Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Plasma Protein Therapeutics Market CR5 and HHI
4.8.2 2023 Plasma Protein Therapeutics Tier 1, Tier 2, and Tier 3
5 Plasma Protein Therapeutics Market by Type
5.1 Global Plasma Protein Therapeutics Revenue by Type
5.1.1 Global Plasma Protein Therapeutics Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Plasma Protein Therapeutics Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Plasma Protein Therapeutics Revenue Market Share by Type (2019-2030)
5.2 Global Plasma Protein Therapeutics Sales by Type
5.2.1 Global Plasma Protein Therapeutics Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Plasma Protein Therapeutics Sales by Type (2019-2030) & (K Units)
5.2.3 Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2030)
5.3 Global Plasma Protein Therapeutics Price by Type
6 Plasma Protein Therapeutics Market by Application
6.1 Global Plasma Protein Therapeutics Revenue by Application
6.1.1 Global Plasma Protein Therapeutics Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Plasma Protein Therapeutics Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Plasma Protein Therapeutics Revenue Market Share by Application (2019-2030)
6.2 Global Plasma Protein Therapeutics Sales by Application
6.2.1 Global Plasma Protein Therapeutics Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Plasma Protein Therapeutics Sales by Application (2019-2030) & (K Units)
6.2.3 Global Plasma Protein Therapeutics Sales Market Share by Application (2019-2030)
6.3 Global Plasma Protein Therapeutics Price by Application
7 Company Profiles
7.1 Shire (Baxalta)
7.1.1 Shire (Baxalta) Comapny Information
7.1.2 Shire (Baxalta) Business Overview
7.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio
7.1.5 Shire (Baxalta) Recent Developments
7.2 CSL
7.2.1 CSL Comapny Information
7.2.2 CSL Business Overview
7.2.3 CSL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 CSL Plasma Protein Therapeutics Product Portfolio
7.2.5 CSL Recent Developments
7.3 Grifols
7.3.1 Grifols Comapny Information
7.3.2 Grifols Business Overview
7.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Grifols Plasma Protein Therapeutics Product Portfolio
7.3.5 Grifols Recent Developments
7.4 Octapharma
7.4.1 Octapharma Comapny Information
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Octapharma Plasma Protein Therapeutics Product Portfolio
7.4.5 Octapharma Recent Developments
7.5 Kedrion
7.5.1 Kedrion Comapny Information
7.5.2 Kedrion Business Overview
7.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Kedrion Plasma Protein Therapeutics Product Portfolio
7.5.5 Kedrion Recent Developments
7.6 LFB Group
7.6.1 LFB Group Comapny Information
7.6.2 LFB Group Business Overview
7.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 LFB Group Plasma Protein Therapeutics Product Portfolio
7.6.5 LFB Group Recent Developments
7.7 Biotest
7.7.1 Biotest Comapny Information
7.7.2 Biotest Business Overview
7.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Biotest Plasma Protein Therapeutics Product Portfolio
7.7.5 Biotest Recent Developments
7.8 BPL
7.8.1 BPL Comapny Information
7.8.2 BPL Business Overview
7.8.3 BPL Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 BPL Plasma Protein Therapeutics Product Portfolio
7.8.5 BPL Recent Developments
7.9 RAAS
7.9.1 RAAS Comapny Information
7.9.2 RAAS Business Overview
7.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 RAAS Plasma Protein Therapeutics Product Portfolio
7.9.5 RAAS Recent Developments
7.10 CBPO
7.10.1 CBPO Comapny Information
7.10.2 CBPO Business Overview
7.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 CBPO Plasma Protein Therapeutics Product Portfolio
7.10.5 CBPO Recent Developments
7.11 Hualan Bio
7.11.1 Hualan Bio Comapny Information
7.11.2 Hualan Bio Business Overview
7.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Hualan Bio Plasma Protein Therapeutics Product Portfolio
7.11.5 Hualan Bio Recent Developments
7.12 Kamada
7.12.1 Kamada Comapny Information
7.12.2 Kamada Business Overview
7.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Kamada Plasma Protein Therapeutics Product Portfolio
7.12.5 Kamada Recent Developments
8 North America
8.1 North America Plasma Protein Therapeutics Market Size by Type
8.1.1 North America Plasma Protein Therapeutics Revenue by Type (2019-2030)
8.1.2 North America Plasma Protein Therapeutics Sales by Type (2019-2030)
8.1.3 North America Plasma Protein Therapeutics Price by Type (2019-2030)
8.2 North America Plasma Protein Therapeutics Market Size by Application
8.2.1 North America Plasma Protein Therapeutics Revenue by Application (2019-2030)
8.2.2 North America Plasma Protein Therapeutics Sales by Application (2019-2030)
8.2.3 North America Plasma Protein Therapeutics Price by Application (2019-2030)
8.3 North America Plasma Protein Therapeutics Market Size by Country
8.3.1 North America Plasma Protein Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Plasma Protein Therapeutics Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Plasma Protein Therapeutics Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Plasma Protein Therapeutics Market Size by Type
9.1.1 Europe Plasma Protein Therapeutics Revenue by Type (2019-2030)
9.1.2 Europe Plasma Protein Therapeutics Sales by Type (2019-2030)
9.1.3 Europe Plasma Protein Therapeutics Price by Type (2019-2030)
9.2 Europe Plasma Protein Therapeutics Market Size by Application
9.2.1 Europe Plasma Protein Therapeutics Revenue by Application (2019-2030)
9.2.2 Europe Plasma Protein Therapeutics Sales by Application (2019-2030)
9.2.3 Europe Plasma Protein Therapeutics Price by Application (2019-2030)
9.3 Europe Plasma Protein Therapeutics Market Size by Country
9.3.1 Europe Plasma Protein Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Plasma Protein Therapeutics Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Plasma Protein Therapeutics Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Plasma Protein Therapeutics Market Size by Type
10.1.1 China Plasma Protein Therapeutics Revenue by Type (2019-2030)
10.1.2 China Plasma Protein Therapeutics Sales by Type (2019-2030)
10.1.3 China Plasma Protein Therapeutics Price by Type (2019-2030)
10.2 China Plasma Protein Therapeutics Market Size by Application
10.2.1 China Plasma Protein Therapeutics Revenue by Application (2019-2030)
10.2.2 China Plasma Protein Therapeutics Sales by Application (2019-2030)
10.2.3 China Plasma Protein Therapeutics Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Plasma Protein Therapeutics Market Size by Type
11.1.1 Asia Plasma Protein Therapeutics Revenue by Type (2019-2030)
11.1.2 Asia Plasma Protein Therapeutics Sales by Type (2019-2030)
11.1.3 Asia Plasma Protein Therapeutics Price by Type (2019-2030)
11.2 Asia Plasma Protein Therapeutics Market Size by Application
11.2.1 Asia Plasma Protein Therapeutics Revenue by Application (2019-2030)
11.2.2 Asia Plasma Protein Therapeutics Sales by Application (2019-2030)
11.2.3 Asia Plasma Protein Therapeutics Price by Application (2019-2030)
11.3 Asia Plasma Protein Therapeutics Market Size by Country
11.3.1 Asia Plasma Protein Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Plasma Protein Therapeutics Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Plasma Protein Therapeutics Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Plasma Protein Therapeutics Market Size by Type
12.1.1 MEALA Plasma Protein Therapeutics Revenue by Type (2019-2030)
12.1.2 MEALA Plasma Protein Therapeutics Sales by Type (2019-2030)
12.1.3 MEALA Plasma Protein Therapeutics Price by Type (2019-2030)
12.2 MEALA Plasma Protein Therapeutics Market Size by Application
12.2.1 MEALA Plasma Protein Therapeutics Revenue by Application (2019-2030)
12.2.2 MEALA Plasma Protein Therapeutics Sales by Application (2019-2030)
12.2.3 MEALA Plasma Protein Therapeutics Price by Application (2019-2030)
12.3 MEALA Plasma Protein Therapeutics Market Size by Country
12.3.1 MEALA Plasma Protein Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Plasma Protein Therapeutics Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Plasma Protein Therapeutics Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Plasma Protein Therapeutics Value Chain Analysis
13.1.1 Plasma Protein Therapeutics Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Plasma Protein Therapeutics Production Mode & Process
13.2 Plasma Protein Therapeutics Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Plasma Protein Therapeutics Distributors
13.2.3 Plasma Protein Therapeutics Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Plasma Protein Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Coagulation Factor Major Manufacturers
Table 3. Immune Globulin Major Manufacturers
Table 4. Albumin Major Manufacturers
Table 5. Others Major Manufacturers
Table 6. Global Plasma Protein Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Hemophilia Major Manufacturers
Table 8. PID Major Manufacturers
Table 9. Others Major Manufacturers
Table 10. Plasma Protein Therapeutics Industry Trends
Table 11. Plasma Protein Therapeutics Industry Drivers
Table 12. Plasma Protein Therapeutics Industry Opportunities and Challenges
Table 13. Plasma Protein Therapeutics Industry Restraints
Table 14. Global Plasma Protein Therapeutics Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 15. Global Plasma Protein Therapeutics Revenue by Region (2019-2024) & (US$ Million)
Table 16. Global Plasma Protein Therapeutics Revenue by Region (2025-2030) & (US$ Million)
Table 17. Global Plasma Protein Therapeutics Revenue Market Share by Region (2019-2024)
Table 18. Global Plasma Protein Therapeutics Revenue Market Share by Region (2025-2030)
Table 19. Global Plasma Protein Therapeutics Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Table 20. Global Plasma Protein Therapeutics Sales by Region (2019-2024) & (K Units)
Table 21. Global Plasma Protein Therapeutics Sales by Region (2025-2030) & (K Units)
Table 22. Global Plasma Protein Therapeutics Sales Market Share by Region (2019-2024)
Table 23. Global Plasma Protein Therapeutics Sales Market Share by Region (2025-2030)
Table 24. Global Plasma Protein Therapeutics Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Plasma Protein Therapeutics Revenue Market Share by Manufacturers (2019-2024)
Table 26. Global Plasma Protein Therapeutics Sales by Manufacturers (US$ Million) & (2019-2024)
Table 27. Global Plasma Protein Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 28. Global Plasma Protein Therapeutics Sales Price (USD/Unit) of Manufacturers (2019-2024)
Table 29. Global Plasma Protein Therapeutics Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 30. Global Plasma Protein Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
Table 31. Global Plasma Protein Therapeutics Manufacturers, Product Type & Application
Table 32. Global Plasma Protein Therapeutics Manufacturers Commercialization Time
Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Plasma Protein Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 35. Global Plasma Protein Therapeutics Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global Plasma Protein Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 37. Global Plasma Protein Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 38. Global Plasma Protein Therapeutics Revenue Market Share by Type (2019-2024)
Table 39. Global Plasma Protein Therapeutics Revenue Market Share by Type (2025-2030)
Table 40. Global Plasma Protein Therapeutics Sales by Type 2019 VS 2023 VS 2030 (K Units)
Table 41. Global Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 42. Global Plasma Protein Therapeutics Sales by Type (2025-2030) & (K Units)
Table 43. Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2024)
Table 44. Global Plasma Protein Therapeutics Sales Market Share by Type (2025-2030)
Table 45. Global Plasma Protein Therapeutics Price by Type (2019-2024) & (USD/Unit)
Table 46. Global Plasma Protein Therapeutics Price by Type (2025-2030) & (USD/Unit)
Table 47. Global Plasma Protein Therapeutics Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global Plasma Protein Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 49. Global Plasma Protein Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 50. Global Plasma Protein Therapeutics Revenue Market Share by Application (2019-2024)
Table 51. Global Plasma Protein Therapeutics Revenue Market Share by Application (2025-2030)
Table 52. Global Plasma Protein Therapeutics Sales by Application 2019 VS 2023 VS 2030 (K Units)
Table 53. Global Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 54. Global Plasma Protein Therapeutics Sales by Application (2025-2030) & (K Units)
Table 55. Global Plasma Protein Therapeutics Sales Market Share by Application (2019-2024)
Table 56. Global Plasma Protein Therapeutics Sales Market Share by Application (2025-2030)
Table 57. Global Plasma Protein Therapeutics Price by Application (2019-2024) & (USD/Unit)
Table 58. Global Plasma Protein Therapeutics Price by Application (2025-2030) & (USD/Unit)
Table 59. Shire (Baxalta) Company Information
Table 60. Shire (Baxalta) Business Overview
Table 61. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 62. Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio
Table 63. Shire (Baxalta) Recent Development
Table 64. CSL Company Information
Table 65. CSL Business Overview
Table 66. CSL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 67. CSL Plasma Protein Therapeutics Product Portfolio
Table 68. CSL Recent Development
Table 69. Grifols Company Information
Table 70. Grifols Business Overview
Table 71. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Grifols Plasma Protein Therapeutics Product Portfolio
Table 73. Grifols Recent Development
Table 74. Octapharma Company Information
Table 75. Octapharma Business Overview
Table 76. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Octapharma Plasma Protein Therapeutics Product Portfolio
Table 78. Octapharma Recent Development
Table 79. Kedrion Company Information
Table 80. Kedrion Business Overview
Table 81. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Kedrion Plasma Protein Therapeutics Product Portfolio
Table 83. Kedrion Recent Development
Table 84. LFB Group Company Information
Table 85. LFB Group Business Overview
Table 86. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. LFB Group Plasma Protein Therapeutics Product Portfolio
Table 88. LFB Group Recent Development
Table 89. Biotest Company Information
Table 90. Biotest Business Overview
Table 91. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Biotest Plasma Protein Therapeutics Product Portfolio
Table 93. Biotest Recent Development
Table 94. BPL Company Information
Table 95. BPL Business Overview
Table 96. BPL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. BPL Plasma Protein Therapeutics Product Portfolio
Table 98. BPL Recent Development
Table 99. RAAS Company Information
Table 100. RAAS Business Overview
Table 101. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. RAAS Plasma Protein Therapeutics Product Portfolio
Table 103. RAAS Recent Development
Table 104. CBPO Company Information
Table 105. CBPO Business Overview
Table 106. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. CBPO Plasma Protein Therapeutics Product Portfolio
Table 108. CBPO Recent Development
Table 109. Hualan Bio Company Information
Table 110. Hualan Bio Business Overview
Table 111. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Hualan Bio Plasma Protein Therapeutics Product Portfolio
Table 113. Hualan Bio Recent Development
Table 114. Kamada Company Information
Table 115. Kamada Business Overview
Table 116. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Kamada Plasma Protein Therapeutics Product Portfolio
Table 118. Kamada Recent Development
Table 119. North America Plasma Protein Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 120. North America Plasma Protein Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 121. North America Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 122. North America Plasma Protein Therapeutics Sales by Type (2025-2030) & (K Units)
Table 123. North America Plasma Protein Therapeutics Sales Price by Type (2019-2024) & (USD/Unit)
Table 124. North America Plasma Protein Therapeutics Sales Price by Type (2025-2030) & (USD/Unit)
Table 125. North America Plasma Protein Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 126. North America Plasma Protein Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 127. North America Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 128. North America Plasma Protein Therapeutics Sales by Application (2025-2030) & (K Units)
Table 129. North America Plasma Protein Therapeutics Sales Price by Application (2019-2024) & (USD/Unit)
Table 130. North America Plasma Protein Therapeutics Sales Price by Application (2025-2030) & (USD/Unit)
Table 131. North America Plasma Protein Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 132. North America Plasma Protein Therapeutics Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 133. North America Plasma Protein Therapeutics Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 134. North America Plasma Protein Therapeutics Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 135. North America Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 136. North America Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)
Table 137. North America Plasma Protein Therapeutics Sales Price by Country (2019-2024) & (USD/Unit)
Table 138. North America Plasma Protein Therapeutics Sales Price by Country (2025-2030) & (USD/Unit)
Table 139. US Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 140. Canada Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 141. Europe Plasma Protein Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 142. Europe Plasma Protein Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 143. Europe Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 144. Europe Plasma Protein Therapeutics Sales by Type (2025-2030) & (K Units)
Table 145. Europe Plasma Protein Therapeutics Sales Price by Type (2019-2024) & (USD/Unit)
Table 146. Europe Plasma Protein Therapeutics Sales Price by Type (2025-2030) & (USD/Unit)
Table 147. Europe Plasma Protein Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 148. Europe Plasma Protein Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 149. Europe Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 150. Europe Plasma Protein Therapeutics Sales by Application (2025-2030) & (K Units)
Table 151. Europe Plasma Protein Therapeutics Sales Price by Application (2019-2024) & (USD/Unit)
Table 152. Europe Plasma Protein Therapeutics Sales Price by Application (2025-2030) & (USD/Unit)
Table 153. Europe Plasma Protein Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 154. Europe Plasma Protein Therapeutics Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 155. Europe Plasma Protein Therapeutics Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 156. Europe Plasma Protein Therapeutics Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 157. Europe Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 158. Europe Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)
Table 159. Europe Plasma Protein Therapeutics Sales Price by Country (2019-2024) & (USD/Unit)
Table 160. Europe Plasma Protein Therapeutics Sales Price by Country (2025-2030) & (USD/Unit)
Table 161. Germany Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 162. France Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 163. Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 164. Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 165. Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 166. China Plasma Protein Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 167. China Plasma Protein Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 168. China Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 169. China Plasma Protein Therapeutics Sales by Type (2025-2030) & (K Units)
Table 170. China Plasma Protein Therapeutics Sales Price by Type (2019-2024) & (USD/Unit)
Table 171. China Plasma Protein Therapeutics Sales Price by Type (2025-2030) & (USD/Unit)
Table 172. China Plasma Protein Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 173. China Plasma Protein Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 174. China Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 175. China Plasma Protein Therapeutics Sales by Application (2025-2030) & (K Units)
Table 176. China Plasma Protein Therapeutics Sales Price by Application (2019-2024) & (USD/Unit)
Table 177. China Plasma Protein Therapeutics Sales Price by Application (2025-2030) & (USD/Unit)
Table 178. Asia Plasma Protein Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 179. Asia Plasma Protein Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 180. Asia Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 181. Asia Plasma Protein Therapeutics Sales by Type (2025-2030) & (K Units)
Table 182. Asia Plasma Protein Therapeutics Sales Price by Type (2019-2024) & (USD/Unit)
Table 183. Asia Plasma Protein Therapeutics Sales Price by Type (2025-2030) & (USD/Unit)
Table 184. Asia Plasma Protein Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 185. Asia Plasma Protein Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 186. Asia Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 187. Asia Plasma Protein Therapeutics Sales by Application (2025-2030) & (K Units)
Table 188. Asia Plasma Protein Therapeutics Sales Price by Application (2019-2024) & (USD/Unit)
Table 189. Asia Plasma Protein Therapeutics Sales Price by Application (2025-2030) & (USD/Unit)
Table 190. Asia Plasma Protein Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 191. Asia Plasma Protein Therapeutics Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 192. Asia Plasma Protein Therapeutics Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 193. Asia Plasma Protein Therapeutics Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 194. Asia Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 195. Asia Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)
Table 196. Asia Plasma Protein Therapeutics Sales Price by Country (2019-2024) & (USD/Unit)
Table 197. Asia Plasma Protein Therapeutics Sales Price by Country (2025-2030) & (USD/Unit)
Table 198. Japan Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 199. South Korea Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 200. Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 201. Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 202. Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 203. Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 204. Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 205. Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 206. MEALA Plasma Protein Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 207. MEALA Plasma Protein Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 208. MEALA Plasma Protein Therapeutics Sales by Type (2019-2024) & (K Units)
Table 209. MEALA Plasma Protein Therapeutics Sales by Type (2025-2030) & (K Units)
Table 210. MEALA Plasma Protein Therapeutics Sales Price by Type (2019-2024) & (USD/Unit)
Table 211. MEALA Plasma Protein Therapeutics Sales Price by Type (2025-2030) & (USD/Unit)
Table 212. MEALA Plasma Protein Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 213. MEALA Plasma Protein Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 214. MEALA Plasma Protein Therapeutics Sales by Application (2019-2024) & (K Units)
Table 215. MEALA Plasma Protein Therapeutics Sales by Application (2025-2030) & (K Units)
Table 216. MEALA Plasma Protein Therapeutics Sales Price by Application (2019-2024) & (USD/Unit)
Table 217. MEALA Plasma Protein Therapeutics Sales Price by Application (2025-2030) & (USD/Unit)
Table 218. MEALA Plasma Protein Therapeutics Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 219. MEALA Plasma Protein Therapeutics Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 220. MEALA Plasma Protein Therapeutics Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 221. MEALA Plasma Protein Therapeutics Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 222. MEALA Plasma Protein Therapeutics Sales by Country (2019-2024) & (K Units)
Table 223. MEALA Plasma Protein Therapeutics Sales by Country (2025-2030) & (K Units)
Table 224. MEALA Plasma Protein Therapeutics Sales Price by Country (2019-2024) & (USD/Unit)
Table 225. MEALA Plasma Protein Therapeutics Sales Price by Country (2025-2030) & (USD/Unit)
Table 226. Mexico Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 227. Brazil Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 228. Israel Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 229. Argentina Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 230. Colombia Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 231. Turkey Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 232. Saudi Arabia Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 233. UAE Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Table 234. Key Raw Materials
Table 235. Raw Materials Key Suppliers
Table 236. Plasma Protein Therapeutics Distributors List
Table 237. Plasma Protein Therapeutics Customers List
Table 238. Research Programs/Design for This Report
Table 239. Authors List of This Report
Table 240. Secondary Sources
Table 241. Primary Sources
List of Figures
Figure 1. Plasma Protein Therapeutics Product Picture
Figure 2. Global Plasma Protein Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Plasma Protein Therapeutics Market Size Share 2019 VS 2023 VS 2030
Figure 4. Coagulation Factor Picture
Figure 5. Immune Globulin Picture
Figure 6. Albumin Picture
Figure 7. Others Picture
Figure 8. Global Plasma Protein Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 9. Global Plasma Protein Therapeutics Market Size Share 2019 VS 2023 VS 2030
Figure 10. Hemophilia Picture
Figure 11. PID Picture
Figure 12. Others Picture
Figure 13. Global Plasma Protein Therapeutics Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Plasma Protein Therapeutics Revenue (2019-2030) & (US$ Million)
Figure 15. Global Plasma Protein Therapeutics Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 16. Global Plasma Protein Therapeutics Revenue Market Share by Region: 2023 Versus 2030
Figure 17. Global Plasma Protein Therapeutics Revenue Market Share by Region (2019-2030)
Figure 18. Global Plasma Protein Therapeutics Sales (2019-2030) & (K Units)
Figure 19. Global Plasma Protein Therapeutics Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 20. Global Plasma Protein Therapeutics Sales Market Share by Region (2019-2030)
Figure 21. US & Canada Plasma Protein Therapeutics Sales YoY (2019-2030) & (K Units)
Figure 22. Europe Plasma Protein Therapeutics Sales YoY (2019-2030) & (K Units)
Figure 23. China Plasma Protein Therapeutics Sales YoY (2019-2030) & (K Units)
Figure 24. Asia (Excluding China) Plasma Protein Therapeutics Sales YoY (2019-2030) & (K Units)
Figure 25. Middle East, Africa and Latin America (Excluding China) Plasma Protein Therapeutics Sales YoY (2019-2030) & (K Units)
Figure 26. Global Plasma Protein Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 27. Global Plasma Protein Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 29. Global Plasma Protein Therapeutics Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 30. Global Plasma Protein Therapeutics Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 31. Global Plasma Protein Therapeutics Revenue Market Share by Type (2019-2030)
Figure 32. Global Plasma Protein Therapeutics Sales by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 33. Global Plasma Protein Therapeutics Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 34. Global Plasma Protein Therapeutics Sales Market Share by Type (2019-2030)
Figure 35. Global Plasma Protein Therapeutics Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 36. Global Plasma Protein Therapeutics Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 37. Global Plasma Protein Therapeutics Revenue Market Share by Application (2019-2030)
Figure 38. Global Plasma Protein Therapeutics Sales by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 39. Global Plasma Protein Therapeutics Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 40. Global Plasma Protein Therapeutics Sales Market Share by Application (2019-2030)
Figure 41. North America Plasma Protein Therapeutics Revenue Share by Type (2019-2030)
Figure 42. North America Plasma Protein Therapeutics Sales Share by Type (2019-2030)
Figure 43. North America Plasma Protein Therapeutics Revenue Share by Application (2019-2030)
Figure 44. North America Plasma Protein Therapeutics Sales Share by Application (2019-2030)
Figure 45. North America Plasma Protein Therapeutics Revenue Share by Country (2019-2030)
Figure 46. North America Plasma Protein Therapeutics Sales Share by Country (2019-2030)
Figure 47. Europe Plasma Protein Therapeutics Revenue Share by Type (2019-2030)
Figure 48. Europe Plasma Protein Therapeutics Sales Share by Type (2019-2030)
Figure 49. Europe Plasma Protein Therapeutics Revenue Share by Application (2019-2030)
Figure 50. Europe Plasma Protein Therapeutics Sales Share by Application (2019-2030)
Figure 51. Europe Plasma Protein Therapeutics Revenue Share by Country (2019-2030)
Figure 52. Europe Plasma Protein Therapeutics Sales Share by Country (2019-2030)
Figure 53. China Plasma Protein Therapeutics Revenue Share by Type (2019-2030)
Figure 54. China Plasma Protein Therapeutics Sales Share by Type (2019-2030)
Figure 55. China Plasma Protein Therapeutics Revenue Share by Application (2019-2030)
Figure 56. China Plasma Protein Therapeutics Sales Share by Application (2019-2030)
Figure 57. Asia Plasma Protein Therapeutics Revenue Share by Type (2019-2030)
Figure 58. Asia Plasma Protein Therapeutics Sales Share by Type (2019-2030)
Figure 59. Asia Plasma Protein Therapeutics Revenue Share by Application (2019-2030)
Figure 60. Asia Plasma Protein Therapeutics Sales Share by Application (2019-2030)
Figure 61. Asia Plasma Protein Therapeutics Revenue Share by Country (2019-2030)
Figure 62. Asia Plasma Protein Therapeutics Sales Share by Country (2019-2030)
Figure 63. MEALA Plasma Protein Therapeutics Revenue Share by Type (2019-2030)
Figure 64. MEALA Plasma Protein Therapeutics Sales Share by Type (2019-2030)
Figure 65. MEALA Plasma Protein Therapeutics Revenue Share by Application (2019-2030)
Figure 66. MEALA Plasma Protein Therapeutics Sales Share by Application (2019-2030)
Figure 67. MEALA Plasma Protein Therapeutics Revenue Share by Country (2019-2030)
Figure 68. MEALA Plasma Protein Therapeutics Sales Share by Country (2019-2030)
Figure 69. Plasma Protein Therapeutics Value Chain
Figure 70. Manufacturing Cost Structure
Figure 71. Plasma Protein Therapeutics Production Mode & Process
Figure 72. Direct Comparison with Distribution Share
Figure 73. Distributors Profiles
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
